G1 THERAPEUTICS INC's ticker is GTHX and the CUSIP is 3621LQ109. A total of 102 filers reported holding G1 THERAPEUTICS INC in Q3 2022. The put-call ratio across all filers is 0.54 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2022 | $55,000 | -40.2% | 11,220 | -7.7% | 0.06% | -23.7% |
| Q1 2022 | $92,000 | -78.3% | 12,152 | -70.7% | 0.08% | -77.7% |
| Q4 2021 | $424,000 | -49.8% | 41,480 | -34.1% | 0.34% | -48.2% |
| Q3 2021 | $844,000 | -35.7% | 62,912 | +5.2% | 0.66% | -34.5% |
| Q2 2021 | $1,312,000 | -6.1% | 59,814 | +3.0% | 1.00% | -16.7% |
| Q1 2021 | $1,397,000 | +112.6% | 58,064 | +59.0% | 1.20% | +97.2% |
| Q4 2020 | $657,000 | – | 36,526 | – | 0.61% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| MPM BioImpact LLC | 650,000 | $3,529,500 | 0.92% |
| CHI Advisors LLC | 333,945 | $1,813,321 | 0.48% |
| PVG ASSET MANAGEMENT CORP | 15,585 | $84,626 | 0.37% |
| Rhenman & Partners Asset Management AB | 370,000 | $2,009,100 | 0.21% |
| NEEDHAM INVESTMENT MANAGEMENT LLC | 184,000 | $999,120 | 0.18% |
| Birchview Capital, LP | 40,000 | $217 | 0.15% |
| XTX Topco Ltd | 102,282 | $555,391 | 0.12% |
| Tekla Capital Management LLC | 423,869 | $2,301,609 | 0.09% |
| Woodline Partners LP | 1,028,967 | $5,587,291 | 0.08% |
| Curi Wealth Management, LLC | 81,009 | $439,879 | 0.06% |